Sentence examples for efficacy pattern from inspiring English sources

This in general could not be confirmed in the protocols using diclazuril, which showed a much lower and mostly variable efficacy pattern.

The data presented indicate an advantageous safety profile and efficacy pattern of PXL150, which warrants further clinical investigations of the potential of this peptide in the treatment of SSTIs.

Although the exact contribution of the active metabolite SU12662 to the toxicity and efficacy pattern of sunitinib in humans is unknown, preclinical data point towards equipotent inhibitory capacities (Baratte et al, 2004).

25 Since there is an order of magnitude difference between efficacy pattern by different inhibitors, where uncompetitive inhibitors seem to be the most potent, it might be relevant to interrogate what value GKD brings to the anti-infective drug-discovery programs.

AA metabolism pathway was selected to elucidate the special efficacy patterns of DQP.

In the last two decades multi drug resistant microorganisms (both hospital- and community-acquired) challenged the scientific groups into developing new antimicrobial compounds that can provide safety in use according to the new regulation, good efficacy patterns, and low resistance profile.

This study evaluates the efficacy of pattern modulation GC×GC by analyzing a standard mixture of 43 oxygenated organic compounds and an E85 fuel sample.

Naturalistic studies to assess the efficacy and pattern of use of computer-delivered psychotherapy programmes in real daily clinical conditions are infrequent.

The forest plots of the prespecified subgroup analyses appear in Figures S2 and S3. 29, 31 With respect to efficacy, the pattern of treatment effect across these major subgroups age, sex, weight, risk factors, renal function, and region all tend to favor apixaban, and do not reveal evidence of a treatment interaction.

Hence, it is already the practice in many CF centers to employ sequential antibiotic treatment regimes with alternate use of inhaled tobramycin and colistin or other combinations for P. aeruginosa suppressive therapy, although clinical trials examining efficacy, resistance pattern, and safety are lacking.

The secondary endpoints are varied and include efficacy and practice pattern data.